IL33 and inflammation: Expansion of ILC2s and activation by IL-33 from damaged parenchymal cells results in IL-13 production driving fibrotic gene expression in hepatic stellate cells in fibrosis models, or IL-5 production with resultant hepatic inflammation and eosinophilia in immune-mediated hepatitis models (265, 266).